![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
1. Polymyxin B, Sulfate (salt)
2. 1405-20-5
3. Polymixin B Sulphate
4. Ks-1428
5. Pmb
6. Akos025392172
7. Polymyxin B Sulfate, Bacillus Polymyxa
8. M02428
9. Polymyxin B Sulfate (1404-26-8 Free Base)
10. 405p205
Molecular Weight | 1301.6 g/mol |
---|---|
Molecular Formula | C56H100N16O17S |
Hydrogen Bond Donor Count | 20 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 29 |
Exact Mass | 1300.71730696 g/mol |
Monoisotopic Mass | 1300.71730696 g/mol |
Topological Polar Surface Area | 574 Ų |
Heavy Atom Count | 90 |
Formal Charge | 0 |
Complexity | 2240 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Polymyxin b sulfate |
Drug Label | Polymyxin B for Injection, USP is one of a group of basic polypeptide antibiotics derived from B polymyxa (B aerosporous). Polymyxin B sulfate is the sulfate salt of Polymyxins B1 and B2, which are produced by the growth of Bacillus polymyxa (Prazmow... |
Active Ingredient | Polymyxin b sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500,000 u base/vial |
Market Status | Prescription |
Company | X Gen Pharms; Xellia Pharms Aps; Fresenius Kabi Usa; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Polymyxin b sulfate |
Drug Label | Polymyxin B for Injection, USP is one of a group of basic polypeptide antibiotics derived from B polymyxa (B aerosporous). Polymyxin B sulfate is the sulfate salt of Polymyxins B1 and B2, which are produced by the growth of Bacillus polymyxa (Prazmow... |
Active Ingredient | Polymyxin b sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500,000 u base/vial |
Market Status | Prescription |
Company | X Gen Pharms; Xellia Pharms Aps; Fresenius Kabi Usa; Eurohlth Intl |